MRP Capital Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Hold
650
0.17% 81
2026
Q1
$229K Hold
650
0.2% 76
2025
Q4
$213K Hold
650
0.18% 87
2025
Q3
$181K Buy
+650
New +$189K 0.16% 95
2025
Q2
Sell
-700
Closed -$218K 196
2025
Q1
$218K Hold
700
0.2% 89
2024
Q4
$182K Hold
700
0.17% 91
2024
Q3
$226K Hold
700
0.21% 94
2024
Q2
$219K Buy
+700
New +$206K 0.2% 96
2024
Q1
Sell
-1,300
Closed -$374K 101
2023
Q4
$374K Buy
1,300
+250
+24% +$68.1K 0.4% 74
2023
Q3
$282K Sell
1,050
-75
-7% -$18.7K 0.31% 81
2023
Q2
$250K Hold
1,125
0.24% 95
2023
Q1
$272K Buy
1,125
+200
+22% +$49.1K 0.3% 78
2022
Q4
$243K Buy
+925
New +$248K 0.27% 80

Other funds holding AMGN

MRP Capital Investments's AMGN Position: Q2 2026 in Review

MRP Capital Investments held its Amgen (AMGN) position steady in Q2 2026 at 650 shares worth $235K. The position accounts for 0.17% of the portfolio, ranked #81.

MRP Capital Investments first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $374K in Q4 2023. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MRP Capital Investments held 650 shares of Amgen worth $235K as of Q2 2026.
  • MRP Capital Investments left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.17% of MRP Capital Investments's portfolio in Q2 2026, its #81 holding.
  • MRP Capital Investments first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
  • MRP Capital Investments's Amgen position peaked at $374K in Q4 2023.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MRP Capital Investments's 13F filing for Q2 2026, filed 10 Aug 2026.